10.6084/m9.figshare.11550561.v1 Alessandro Russo Alessandro Russo Marco Russano Marco Russano Tindara Franchina Tindara Franchina Maria R Migliorino Maria R Migliorino Giuseppe Aprile Giuseppe Aprile Giovanni Mansueto Giovanni Mansueto Alfredo Berruti Alfredo Berruti Alfredo Falcone Alfredo Falcone Michele Aieta Michele Aieta Alain Gelibter Alain Gelibter Antonio Russo Antonio Russo Sandro Barni Sandro Barni Michele Maio Michele Maio Olga Martelli Olga Martelli Francesco Pantano Francesco Pantano Daniela Iacono Daniela Iacono Lorenzo Calvetti Lorenzo Calvetti Silvia Quadrini Silvia Quadrini Elisa Roca Elisa Roca Enrico Vasile Enrico Vasile Marco Imperatori Marco Imperatori Mario Occhipinti Mario Occhipinti Antonio Galvano Antonio Galvano Fausto Petrelli Fausto Petrelli Luana Calabrò Luana Calabrò Giulia Pasquini Giulia Pasquini Salvatore Intagliata Salvatore Intagliata Giuseppina R.R. Ricciardi Giuseppina R.R. Ricciardi Giuseppe Tonini Giuseppe Tonini Daniele Santini Daniele Santini Vincenzo Adamo Vincenzo Adamo Neutrophil-To-Lymphocyte Ratio (NLR) Platelet-To-Lymphocyte Ratio (PLR), and Outcomes With Nivolumab in Pretreated Non-Small Cell Lung Cancer (NSCLC): A Large Retrospective Multicenter Study Adis Journals 2020 LDH Nivolumab NLR NSCLC PD-1 PD-L1 PLR Prognosis 2020-01-27 12:16:53 Figure https://adisjournals.figshare.com/articles/figure/Neutrophil-To-Lymphocyte_Ratio_NLR_Platelet-To-Lymphocyte_Ratio_PLR_and_Outcomes_With_Nivolumab_in_Pretreated_Non-Small_Cell_Lung_Cancer_NSCLC_A_Large_Retrospective_Multicenter_Study/11550561 <p> </p> <p><strong>Provide enhanced digital features for this article</strong><br></p><p> This Figshare page contains a Summary Slide. If you are an author of this publication and would like to provide additional enhanced digital features for your article then please contact <u>adisrapidplus@springer.com</u>.<br> <br> The journal offers a range of additional features designed to increase visibility and readership. All features will be thoroughly peer reviewed to ensure the content is of the highest scientific standard and all features are marked as ‘peer reviewed’ to ensure readers are aware that the content has been reviewed to the same level as the articles they are being presented alongside. Moreover, all sponsorship and disclosure information is included to provide complete transparency and adherence to good publication practices. This ensures that however the content is reached the reader has a full understanding of its origin. No fees are charged for hosting additional open access content.<br> <br> Other enhanced features include, but are not limited to:<br> • Slide decks<br> • Videos and animations<br> • Audio abstracts<br> • Audio slides</p> <br> <p> </p>